|We Speak Methadone (and buprenorphine)
|About Buprenorphine Therapy | SAMHSA
|Page 1 of 1|
|Author:||tndirector [ Wed Jul 15, 2015 11:21 am ]|
|Post subject:||About Buprenorphine Therapy | SAMHSA|
About Buprenorphine Therapy
In October 2002, the Food and Drug Administration (FDA) approved buprenorphine products for use in opioid addiction treatment. The buprenorphine products endorsed by the Buprenorphine Products Manufacturers Group, Suboxone Film, and Zubslov Sublingual Tablets are designed to decrease the potential for abuse by injection. These are currently the only Schedule III, IV, or V medications to have received FDA approval for this indication. Note that aside from these buprenorphine products, other forms of buprenorphine (e.g., Buprenex®) are not approved for treatment of opioid addiction.
The FDA approval of these buprenorphine formulations does not affect the status of other medication-assisted opioid addiction treatments, such as methadone. As indicated in Title 42 Code of Federal Regulations Part 8 (42 CFR Part 8), these treatments can only be dispensed, and only in the context of an Opioid Treatment Program. Also, neither the approval of buprenorphine products nor the provisions of DATA 2000, affect the use of other Schedule III, IV, or V medications, such as codeine, that are not approved for the treatment of addiction.
Read MORE about Buprenorphine Therapy from SAMHSA by clicking here: http://buprenorphine.samhsa.gov/about.html
|Page 1 of 1||All times are UTC - 5 hours|
|Powered by phpBB © 2000, 2002, 2005, 2007 phpBB Group